Company registration number SC647727 (Scotland)
MGF HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 5 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
MGF HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MGF HEALTHCARE LIMITED
BALANCE SHEET
AS AT
5 APRIL 2025
05 April 2025
- 1 -
5 April 2025
31 March 2024
Notes
£
£
£
£
Fixed assets
Investments
3
4,944,320
4,944,320
Current assets
Debtors
4
3,115
1,828
Cash at bank and in hand
240,517
284,437
243,632
286,265
Creditors: amounts falling due within one year
5
(254,142)
(550,916)
Net current liabilities
(10,510)
(264,651)
Total assets less current liabilities
4,933,810
4,679,669
Creditors: amounts falling due after more than one year
6
(4,920,297)
(4,669,418)
Net assets
13,513
10,251
Capital and reserves
Called up share capital
7
1
1
Profit and loss reserves
13,512
10,250
Total equity
13,513
10,251

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 5 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 29 September 2025
M Feeney
Director
Company Registration No. SC647727
MGF HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 5 APRIL 2025
- 2 -
1
Accounting policies
Company information

MGF Healthcare Limited is a private company limited by shares incorporated in Scotland. The registered office is 171 Saracen Street, Glasgow, United Kingdom, G22 5JL.

1.1
Reporting period

The Company extended its year end from 31 March 2025 to 5 April 2025.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.5
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

MGF HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 5 APRIL 2025
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2024
Number
Number
Total
-
0
-
0
3
Fixed asset investments
2025
2024
£
£
Other investments other than loans
4,944,320
4,944,320
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
3,115
1,828
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
250,344
547,280
Other creditors
3,798
3,636
254,142
550,916
6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
4,561,784
4,515,193
Other creditors
358,513
154,225
4,920,297
4,669,418
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A Shares of 0.1p each
833
833
1
1
Ordinary B Shares of 0.1p each
51
51
-
0
-
0
Ordinary C Shares of 0.1p each
220
220
-
0
-
0
MGF HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 5 APRIL 2025
7
Called up share capital
(Continued)
- 4 -
8
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Other related parties
358,513
154,225

This loan is unsecured, interest free with no fixed date for repayment.

2025
2024
Amounts due from related parties
£
£
Key management personnel
3,116
1,828

This loan is unsecured, interest free with no fixed date for repayment.

2025-04-05 2024-04-01 false false false 29 September 2025 CCH Software CCH Accounts Production 2025.100 No description of principal activity M Feeney SC647727 2024-04-01 2025-04-05 SC647727 2025-04-05 SC647727 2024-03-31 SC647727 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-05 SC647727 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 SC647727 core:Non-currentFinancialInstruments core:AfterOneYear 2025-04-05 SC647727 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 SC647727 core:CurrentFinancialInstruments 2025-04-05 SC647727 core:CurrentFinancialInstruments 2024-03-31 SC647727 core:Non-currentFinancialInstruments 2025-04-05 SC647727 core:Non-currentFinancialInstruments 2024-03-31 SC647727 core:ShareCapital 2025-04-05 SC647727 core:ShareCapital 2024-03-31 SC647727 core:RetainedEarningsAccumulatedLosses 2025-04-05 SC647727 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC647727 core:ShareCapitalOrdinaryShareClass2 2025-04-05 SC647727 core:ShareCapitalOrdinaryShareClass2 2024-03-31 SC647727 core:ShareCapitalOrdinaryShareClass3 2025-04-05 SC647727 core:ShareCapitalOrdinaryShareClass3 2024-03-31 SC647727 core:ShareCapitalOrdinaryShareClass4 2025-04-05 SC647727 core:ShareCapitalOrdinaryShareClass4 2024-03-31 SC647727 bus:Director1 2024-04-01 2025-04-05 SC647727 2023-04-01 2024-03-31 SC647727 core:WithinOneYear 2025-04-05 SC647727 core:WithinOneYear 2024-03-31 SC647727 bus:OrdinaryShareClass2 2024-04-01 2025-04-05 SC647727 bus:OrdinaryShareClass3 2024-04-01 2025-04-05 SC647727 bus:OrdinaryShareClass4 2024-04-01 2025-04-05 SC647727 bus:OrdinaryShareClass2 2025-04-05 SC647727 bus:OrdinaryShareClass2 2024-03-31 SC647727 bus:OrdinaryShareClass3 2025-04-05 SC647727 bus:OrdinaryShareClass3 2024-03-31 SC647727 bus:OrdinaryShareClass4 2025-04-05 SC647727 bus:OrdinaryShareClass4 2024-03-31 SC647727 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-04-05 SC647727 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-04-05 SC647727 bus:FRS102 2024-04-01 2025-04-05 SC647727 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-04-05 SC647727 bus:FullAccounts 2024-04-01 2025-04-05 xbrli:pure xbrli:shares iso4217:GBP